PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
12-Apr-2021 The Worldwide Leukapheresis Industry is Expected to Reach $91 Billion by 2026 at a CAGR of 8.4% from 2021 - ResearchAndMarkets.com Businesswire
12-Apr-2021 Alira Health Strengthens Its Growth Strategy With a $35M Funding, Led by Creadev Businesswire
12-Apr-2021 Medidata Launches New Functionality to Enable Holistic Risk-Based Quality Management for Clinical Trials Businesswire
12-Apr-2021 Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory Board Businesswire
12-Apr-2021 Echosens Presents at AMCP 2021 Virtual Event: “Modeling the Return on Investment of VCTE for Fatty Liver Disease (FLD) in a General Population Incorporating Device Costs” Businesswire
12-Apr-2021 KD Pharma Acquires Phytoextract and CBD Manufacturing Assets Businesswire
12-Apr-2021 AmerisourceBergen Foundation Donates $700,000 to Boys & Girls Clubs of America to Roll Out COVID-19 Vaccine Education Programs Across the U.S. Businesswire
12-Apr-2021 Worldwide Air Quality Monitoring Industry to 2026 - Featuring Thermo Fisher Scientific, Siemens and Teledyne Technologies Among Others - ResearchAndMarkets.com Businesswire
12-Apr-2021 Philogen Announces Publication of the Construction and Application of an Innovative DNA-Encoded Chemical Library in Nature Chemistry Newswire
12-Apr-2021 Philogen Announces Participation to the 10th World Congress of Melanoma Newswire
12-Apr-2021 OpRegen® Data Update to Be Featured at 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Presentation by Christopher D. Riemann, MD Businesswire
12-Apr-2021 Mirum Pharmaceuticals and Vivet Therapeutics Enter into Exclusive Worldwide Option and License Agreement for Vivet’s Gene Therapy Programs Targeting Progressive Familial Intrahepatic Cholestasis Businesswire
12-Apr-2021 Urovant Sciences Announces U.S. Commercial Launch of GEMTESA® (vibegron) 75 mg Tablets for Patients with Overactive Bladder Businesswire
12-Apr-2021 Day One Appoints Saira Ramasastry to Board of Directors Businesswire
12-Apr-2021 ZOLL Medical Corporation Acquires Respicardia, Inc. Businesswire
12-Apr-2021 Global CNS Therapeutics Industry (2020 to 2025) - Increased Spending on Prescription Drugs Bodes Well for the Market - ResearchAndMarkets.com Businesswire
12-Apr-2021 Marinus Pharmaceuticals Bolsters Leadership Team with Two New Appointments Businesswire
12-Apr-2021 Precision BioSciences Appoints Stanley R. Frankel, M.D. to Board of Directors Businesswire
12-Apr-2021 Sage Therapeutics and Biogen Announce SAGE-324 Phase 2 Placebo-Controlled KINETIC Study in Essential Tremor Met Primary Endpoint Businesswire
12-Apr-2021 Taysha Gene Therapies Acquires Exclusive Worldwide Rights to Clinical-Stage AAV9 Gene Therapy Program, Now Known as TSHA-120, for the Treatment of Giant Axonal Neuropathy, a Rare and Severe Neurodegenerative Disease Businesswire